Description
This compound is a synthetic analog of human glucagon-like peptide-1 (GLP-1) engineered with structural modifications to extend its pharmacokinetic half-life. As a GLP-1 receptor agonist, it has been extensively investigated in preclinical and clinical research for its effects on glucose-dependent insulin secretion, gastric motility, and central appetite regulation. Published studies have demonstrated its relevance in metabolic research models involving glycemic control, body weight regulation, and cardiovascular risk factor modulation. This 10mg lyophilized preparation is intended strictly for in vitro research and laboratory investigation. Not for human consumption.
